A Rapid Vehicle-Screening Approach for Formulating a Low-Solubility Compound into Liquid-Filled Capsules, from Tablets and Capsules

Drug Manufacturers, Technology

A Rapid Vehicle-Screening Approach for Formulating a Low-Solubility Compound into Liquid-Filled Capsules, from Tablets and Capsules

By Patheon

By Amol Kheur, Anil Kane, Mohammad, Aleem, and Maureen McLaughlin, Kiran Kumar Tumbalam and Shivaprakash Poojary

For a drug product to exert its therapeutic effect, it must be soluble in an aqueous environment. This ensures that the active pharmaceutical ingredient (API) will provide sufficient concentration to induce gastrointestinal (GI) tract absorption.

Hence, molecules with promising pharmaco dynamics yet poor solubility may be rejected during the drug discovery stage. This article summarizes how an excipient-mixture approach can enhance the solubility, the in vitro dissolution, and the bioavailability profile of a low-solubility compound.

Download to read more.

This article originally appeared in Tablets & Capsules.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

网曝门